Axogen (AXGN) Net Cash Flow (2010 - 2026)
Axogen's (AXGN) quarterly Net Cash Flow came in at $45.1 million in Q1 2026, up 576.91% year-on-year from $6.7 million in Q1 2025, and up 287.31% quarter-over-quarter from $11.6 million in Q4 2025.
Axogen (AXGN) Net Cash Flow (2010 - 2026) Analysis & Trends
Axogen's Net Cash Flow history runs 17 years deep, the most recent figure standing at $45.1 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 576.91% year-over-year to $45.1 million in Q1 2026; TTM through Mar 2026 was $60.6 million, a 2441.25% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 272.64% from the prior year.
- Net Cash Flow improved to $45.1 million in Q1 2026 per AXGN's latest filing, from $11.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $45.1 million in Q1 2026 and bottomed at -$18.2 million in Q1 2022.
- The 5-year median for Net Cash Flow is $1.9 million (2025), against an average of $2.7 million.
- Across the five-year window, Net Cash Flow sank 120.69% in 2022 and soared 12802.86% in 2024, its largest moves.
- Year by year, Net Cash Flow stood at $966000.0 in 2022, then slumped by 107.25% to -$70000.0 in 2023, then surged by 12802.86% to $8.9 million in 2024, then soared by 30.97% to $11.6 million in 2025, then soared by 287.31% to $45.1 million in 2026.
- Per Business Quant, the three latest AXGN Net Cash Flow figures stand at $45.1 million (Q1 2026), $11.6 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 45.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.11 Mn |
| Mar 31, 2026 | 45.11 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Dec 31, 2024 | 8.89 Mn |
| Dec 31, 2024 | 8.89 Mn |
| Sep 30, 2024 | -527,000.00 |
| Sep 30, 2024 | -527,000.00 |
| Jun 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | -15.31 Mn |
| Mar 31, 2024 | -15.31 Mn |
| Dec 31, 2023 | -70,000.00 |
| Dec 31, 2023 | -70,000.00 |